Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

HMR announces Spanish launch of Telfast

Oct. 9, 1998

Anti-IgE antibody in the treatment of asthma: an interesting theory is validated

Oct. 8, 1998

Genotyping accurately predicts response to treatment with 5-LO inhibitor

Oct. 8, 1998

PAF antagonists in the treatment of asthma: promise or hype?

Oct. 8, 1998

University of Pittsburgh recruits patients for Somnoplasty clinical trial

Oct. 7, 1998

FDA approves Serevent Diskus for maintenance treatment of pediatric asthma

Oct. 7, 1998

Dura and Spiros update development of Spiros products

Oct. 1, 1998

AxyS Pharmaceuticals discontinues development of APC-366 for asthma

Sep. 30, 1998

Dual LTD4 antagonists/histamine release inhibitors in development at Daiichi

Sep. 30, 1998

LCB-2183 inhibits mast cell activation in vivo in mice

Sep. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.